In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Navigating the future of EU merger control: Insights from the “All Points of the Compass” panel at the CRA Brussels Conference 2025
The panel “All Points of the Compass: Navigating the Future of EU Merger Control” discussed the consultation review of the European Commission (EU) guidelines,